Scailyte appoints Tim Foley as Chief Business Officer, Jean-Pierre Rosat as Executive Chair, and Darrin Crisitello as member of the BoD
Biomarker has future applications in new drug candidate identification and could be used in broader cardiovascular and aging-related research.
With this distribution partnership, Witec AG and Scailyte address a long-standing need for a more efficient, cost-effective and insightful single-cell data analysis solution within the Swiss life sciences industry.
Dr. Suso Platero from Janssen Research & Development presenting at the Biomarker Conference to be held on 18-19 February 2016 in San Diego, CA - USA.
The technology can dramatically accelerate the developing diagnostics for personalized medicine and reduce cost